03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Aerinaze* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Abela Freres |
Distributor | Abela Freres |
Laboratory | MSD |
Responsible Party | Merck Sharp & Dohme Ltd |
Origin | UK |
Manufacturer | Schering Plough Labo NV |
Origin | Belgium |
ATC | R01BA52 |
Aerinaze* :
Aerinaze* :
Aerinaze* :
Aerinaze* :
Aerinaze* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Aerinaze* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Uncommon |
Abnormal faeces | Uncommon |
Agitation | Uncommon |
Anaphylaxis | Very rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Very rare |
Anxiety | Uncommon |
Blood bilirubin increased | Very rare |
Chills | Uncommon |
Confusional state | Uncommon |
Constipation | Common |
Convulsion | Very rare |
Decreased appetite | Common |
Diarrhoea (Diarrhea) | Very rare |
Dizziness | Common |
Dry eye | Uncommon |
Dry mouth (Xerostomia) | Common |
Dry throat | Uncommon |
Dyspepsia | Uncommon |
Dyspnoea (dyspnea) | Very rare |
Dysuria (Micturition painful) | Uncommon |
Epistaxis (Nasal bleeding) | Uncommon |
Fatigue | Common |
Flushing | Uncommon |
Gastroenteritis | Uncommon |
Glucosuria (Glycosuria) | Uncommon |
Hallucination | Very rare |
Headache | Common |
Hepatic enzyme increased | Uncommon |
Hepatitis | Very rare |
Hot flush | Uncommon |
Hyperglycaemia | Uncommon |
Hyperkinesia | Uncommon |
Hypersensitivity | Very rare |
Hyposmia | Uncommon |
Insomnia | Common |
Irritability | Uncommon |
Micturition disorder | Uncommon |
Myalgia | Very rare |
Nasal discomfort | Uncommon |
Nausea | Uncommon |
Nervousness | Common |
Palpitations | Uncommon |
Pharyngitis | Common |
Pruritus | Uncommon |
Psychomotor hyperactivity (Psychomotor restlessness) | Common |
Rhinitis | Uncommon |
Rhinorrhoea | Uncommon |
Sinusitis | Uncommon |
Skin rash | Very rare |
Sleep disorder (Sleep disturbance) | Common |
Somnolence | Common |
Supraventricular extrasystoles | Uncommon |
Tachycardia | Common |
Thirst | Uncommon |
Urticaria | Very rare |
Vision blurred | Uncommon |
Vomiting | Very rare |
Aerinaze* :
NB : Products With Same Indication |
Different Units By MoH Code
Aerinaze* MoH 9192 :
Form | Tablet, Prolonged-release |
Packaging | Blisters (PVC/PCTFE/Al) |
Package Size | Box of 14 |
Strength | 2.5mg/120mg |
Storage Condition | <30°C protect from light |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 106417/1 |
Submission date | 01/01/2017 |
Registration Year | 2017 |
Archived Date | 02/03/2020 |
Price Comparison
● Country: | Spain | |
● Package Size: | 10 | |
● Public Price: | 10.3 EUR | ( 997,822.80 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 1,03 EUR | ( 96,876.00 LBP ) |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
● Pricing Date: | 06/05/2021 | |
● Type: | Medicine Non Marketed |
● Country: | Abu Dhabi | |
● Package Size: | 14's Tablet (7's blister X 2) | |
● Public Price: | 26 AED | ( 628,186.00 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 1,8571 AED | ( 24,161.00 LBP ) |
● Pharmacy Price: | 21.1 AED | ( 509797.1 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 10 | |
● Public Price: | 5.7 EUR | ( 552,193.20 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 0,57 EUR | ( 0.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 27/11/2020 | |
● Type: | Medicine Authorised |
● Country: | Bahrain | |
● Package Size: | 14 | |
● Public Price: | 3.34 BHD | ( 794,031.56 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 0,2386 BHD | ( 0.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 09/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Cyprus | |
● Package Size: | 10 TABS | |
● Public Price: | 6.37 EUR | ( 617,100.12 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 0,637 EUR | ( 0.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 24/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Oman | |
● Package Size: | 14 | |
● Public Price: | 2.49 OMR | ( 574,527.66 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 0,1779 OMR | ( 0.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Portugal | |
● Package Size: | 20 | |
● Public Price: | 12.33 EUR | ( 1,194,481.08 LBP ) |
● Pack size unit used: | 20 | |
● Cost/Unit: | 0,6165 EUR | ( 0.00 LBP ) |
● Reference: | Autoridade Nacional do Medicamento e Produtos de Saúde | |
● Pricing Date: | 22/04/2019 | |
● Type: | Medicine Authorised |
● Country: | Finland | |
● Package Size: | 10 | |
● Public Price: | 8.94 EUR | ( 866,071.44 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 0,894 EUR | ( 0.00 LBP ) |
● Reference: | Kela | |
● Pricing Date: | 22/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Greece | |
● Package Size: | 10 | |
● Public Price: | 6.47 EUR | ( 626,787.72 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 0,647 EUR | ( 0.00 LBP ) |
● Exfactory Price: | 4.29 EUR | |
● Pharmacy Price: | 4.52 EUR | ( 437879.52 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 25/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Kuweit | |
● Package Size: | Boîte de 14 | |
● Public Price: | 1.94 KWD | ( 569,547.14 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 0,1386 KWD | ( 0.00 LBP ) |
● Pharmacy Price: | 1.64 KWD | ( 481472.84 LBP ) |
● Pricing Date: | 07/02/2021 | |
● Type: | Medicine Authorised |
Note
You have to register to view this info
Drop File